Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis
Recent studies have indicated that medical options without splenectomy, such as rituximab (RTX) or thrombopoietin receptor agonists (TPO-RAs), can be effective to treat persistent or chronic primary immune thrombocytopenia (ITP). However, it remains to be determined which of these strategies should...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis Group
2019-11-01
|
| Saila: | Platelets |
| Gaiak: | |
| Sarrera elektronikoa: | http://dx.doi.org/10.1080/09537104.2018.1543864 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|